Multiplexed GPCR Characterization Using SPR

使用 SPR 进行多重 GPCR 表征

• 批准号: 8337293
• 负责人: Benjamin Delbert Brooks
• 金额: $ 37.73万
• 依托单位: CARTERRA, INC.
• 依托单位国家: 美国
• 财政年份: 2008
• 资助国家: 美国
• 起止时间: 2008-08-01 至 2014-08-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/8337293
• 关键词: Affect; Antibodies; Automation; Basic Science; Behavior; Binding; Biological Assay; Biosensor; Buffers; CCR5 gene; Cells; Cholesterol; Computer software; Coupling; Data Collection; Detergents; Development; Disease; Drug Delivery Systems; Family; G-Protein-Coupled Receptors; Glycerol; Goals; Health; Hour; Image; Immune system; Label; Learning; Ligand Binding; Lipids; Liquid substance; Marketing; Measurement; Membrane; Membrane Proteins; Microfluidics; Patients; Performance; Pharmaceutical Preparations; Phase; Physiological Processes; Polyethylene Glycols; Positioning Attribute; Printing; Problem Solving; Process; Proteins; Research; Running; Sampling; Screening procedure; Small Business Technology Transfer Research; Smell Perception; Speed; Spottings; Surface; System; Technology; Temperature; Testing; Therapeutic antibodies; Time; Universities; Utah; Vision; Work; biological systems; design; drug development; drug discovery; instrument; mood regulation; novel; receptor; receptor structure function; research study; seal; sensor; success

Project Summary The goal of this Phase II STTR project is to develop a real-time label-free biosensor that can analyze 96 samples at a time, compared to the 6 samples possible with current technologies. This platform will initially be demonstrated with G-protein-coupled receptors (GPCRs) and antibodies. What both applications have in common is the need for higher- throughput sensing, and demonstrating the integrated system for these will illustrate its versatility and potential contributions across the wide spectrum of biosensor applications. For the GPCR demonstration, our work with standard SPR instruments has shown that the choice of detergent(s) is critical for obtaining active solubilized receptor. However, standard low throughput SPR biosensors have two overwhelming drawbacks: (1) The analysis of 96 solubilization conditions requires more than two days and the receptor loses significant activity during this time, which makes it difficult to compare the results obtained at the beginning and end of the analysis and (2) the SPR instrument is limited to testing only one analysis buffer at a time, which means that the success of the entire assay depends on the initial choice of analysis buffer. In Phase I, we developed a 96-channel Continuous Flow Microspotter (CFM) printhead and demonstrated the ability to print GPCRs onto a sensor surface directly from crude media using up to 96 different analysis buffers. The GPCRs were also kept wetted and active throughout the printing process by the CFM's enclosed microchannel printing network. In the final experiment, we solubilized the GPCR CCR5 from whole cells using 192 different detergent conditions and spotted them onto an SPR sensor surface using our CFM printhead. We then tested the activity of the receptor and used the ligand binding results to determine that a certain combination of detergents best enhanced receptor activity. To run this analysis with a standard Biacore technology (e.g. T100) would have required four days of instrument time. In comparison, we were able to perform the analysis in less than 2 hours. In Phase II, we propose to integrate the 96-channel CFM from Phase I with a commercial SPR imager to enable automated interaction analysis in a highly parallel format. The following specific aims detail the combination of Wasatch's microfluidic technologies with the commercial IBIS SPR imager to produce a high-throughput label-free biosensor. 1. Refine the 96-channel CFM printhead design from Phase I to enable optimal performance when mounted on the IBIS SPR imager. 2. Mount the 96-channel CFM onto the IBIS SPR imager and optimize the fluidic parameters that affect platform sensitivity and uniformity. 3. Automate the CFM & SPR components within one seamless instrument: Automation of the flow cell positioning, sealing, fluid handling, valving, in-line degassing and temperature control. Integration of the CFM and SPR imager control software and data collection/analysis software. 4. Demonstrate use of the automated system with GPCRs and antibodies.

项目总结